SLOWLY GOING UP ( same company as THK ) TOOK IT TO $1.50 LAST YEAR ) ---LOADS OF DRILLING TO HAPPEN IN THE NEXT QUARTER
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%